Definitive Healthcare Corp. Hits New 52-Week Low at $1.14

Definitive Healthcare Corp., a microcap company in the Software Products industry, has reached a new 52-week low of USD 1.14 as of February 27, 2026. This significant decline marks a stark contrast to its 52-week high of USD 4.70, reflecting a challenging year for the company with a staggering one-year performance drop of 78.12%. The company's market capitalization stands at USD 214 million, and it currently exhibits a price-to-earnings (P/E) ratio of 6.00. Despite its low valuation, Definitive Healthcare Corp. has struggled with profitability, as indicated by a return on equity (ROE) of 6.08%. The stock's performance has consistently lagged behind the S&P 500, which has gained 17.36% over the same period. Additionally, the company has reported a negative debt-to-equity ratio of -0.06, indicating potential financial instability. With no dividend yield and a price-to-book ratio of 0.75, Definitive Healthcare Corp. continues to face significant challenges in the current market landscape.